Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Telmisartan/Amlodipine FDC Bioavailability
NCT02261064Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan and amlodipine in hypertension (HTN) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from 0 to last quantifiable data point up to 144 hours and Maximum measured concentration up to 144 hours. Started Dec 2008; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02261064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02261064.